News

Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...
Coinbase (NASDAQ:COIN) is working to gain approval from the U.S. Securities and Exchange Commission to offer "tokenized equities" to its customers, the company’s chief legal officer Paul Grewal told ...